Form D — Pharmacy Innovator Fund, a Series of Decile Start Fund, LP
0002125678-26-000001 · filed 2026-04-27
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06c, 3C, 3C.1
- Total offering
- $410,000
- Total sold
- $410,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pharmacy Innovator Fund, a Series of Decile Start Fund, LP
- CIK
- 2125678
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 575 LEXINGTON AVE
NEW YORK, NY 10022 - Phone
- 3014124975
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
- Decile Start Fund GP, LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
- Decile Start Fund Management, LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Gregory Adeodato Ressi di Cervia · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Long Pham · Executive OfficerNew York, NY Find on LinkedIn ↗
-
- Tadrus Advisory Group, LLC · PromoterMoberly, MO Find on LinkedIn ↗
-
Christian Tadrus · PromoterMoberly, MO Find on LinkedIn ↗
View original on SEC EDGAR.